Clinical Trial Update: Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab [Phase 2]

View source ↗

Summary

Phase 2 study comparing Velcade (bortezomib) with fludarabine versus rituximab with fludarabine in follicular lymphoma patients previously treated with rituxima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)
• Rituximab (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Follicular Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2012-11-01